Intraocular Melanoma in Adults

Our eye cancer specialists are leaders in diagnosing and treating intraocular melanoma, which begins in structures within the blood vessel-rich area of the eye known as the uvea. Our internationally recognized ophthalmic oncologists have pioneered many of the vision-sparing diagnostic and treatment approaches currently used for people with intraocular melanoma. Treatment is aimed at destroying the tumor, preserving vision, and preventing the disease from spreading.

Clinical Trials and Research Studies

Phase 2

A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma (mRNA-4157-P201)

Learn More

Phase 1

A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb 20717 in Subjects with Selected Advanced Solid Tumors (DUET-2)

Learn More

Phase 1/2

An Open-Label Multicenter Phase 1/2 Study of RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors

Learn More

Phase 3

Adjuvant Therapy with Pembrolizumab versus Placebo in Resected Highrisk Stage II Melanoma: A Randomized Double-blind Phase 3 Study (KEYNOTE 716)

Learn More